1Eadie MJ.The role of therapeutic drug monitoring in improving the cost effectiveness of anticonvulsant therapy.Clin Pharmacokinet,1995,29:29
2Liu H,Delgado M.Therapeutic drug concentration monitoring using saliva samples.Clin Pharmacokinet,1999,36:453
3Tennison M,Ali I,Miles MV,et al.Feasibility and acceptance of salivary monitoring of antiepileptic drug via the US Post Service.Ther Drug Monit,2004,26:295
4Mikael D.Jones,Melody Ryan,et al.Stability of salivary concentrations of the newer antiepileptic drugs in the Postal System,2005,27:576
5Glauser TA,Pippenger CE.Controversies in blood-level monitoring:re-examining its role in the treatment of epilepsy.Epilepsia,2000,41(suppl 8):s6
6Tomson T,Johannessen SI.Therapeutic monitoring of the new antiepileptic drugs.Eur J Clin Pharmacol,2000,55:697
7Johannessen SI,Battino D,Bery DJ,et al.Therapeutic drug monitoring of the newer antiepileptic drugs.Ther Drug Monit,2003,25:347
8Perucca E,The clinical pharmacokinetics of the new antiepileptic drugs.Epilepsia,1999,40(suppl 9):s7
9Morris RG,Black AB,Harris AL,et al.Lamotrigine and therapeutic drug monitoring:retrospective survey following the introduction of a routine service.Br J Clin Parmacol,1998,46:547
10Tsiropoulos I,Kristensen O,Klitgaard NA,et al.Saliva and serum concentration of lamotrigine in patients with epilepsy.Ther Drug Monit,2000,22:517
